睿昂基因
(688217)
| 流通市值：16.06亿 | | | 总市值：16.06亿 |
| 流通股本：5585.59万 | | | 总股本：5585.59万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 123,252,186.5 | 104,959,064.87 | 113,802,648.68 | 132,407,785.02 |
| 交易性金融资产 | 102,548,709.35 | 120,281,057.92 | 104,493,747.53 | 80,361,104.6 |
| 应收票据及应收账款 | 140,851,153.43 | 144,450,732.52 | 156,725,109.9 | 168,689,759.48 |
| 其中：应收票据 | 319,939.2 | 3,134,375.04 | 1,370,398.89 | 1,973,004.56 |
| 应收账款 | 140,531,214.23 | 141,316,357.48 | 155,354,711.01 | 166,716,754.92 |
| 应收款项融资 | 6,465,320 | 8,056,124 | 6,739,444 | 5,621,518 |
| 预付款项 | 5,388,259.61 | 3,676,702.03 | 7,520,092.61 | 6,472,188.33 |
| 其他应收款合计 | 1,063,635.8 | 1,372,976.44 | 1,973,023.81 | 1,798,250.13 |
| 存货 | 31,642,250 | 32,394,685.08 | 36,798,461.85 | 36,894,050.47 |
| 其他流动资产 | 9,672,041.47 | 12,603,304.42 | 12,080,176.99 | 13,859,052.05 |
| 流动资产合计 | 420,883,556.16 | 427,794,647.28 | 440,132,705.37 | 446,103,708.08 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | 159,005.52 | 159,005.52 |
| 其他权益工具投资 | 43,141,145.12 | 43,141,145.12 | 47,763,354.76 | 47,763,354.76 |
| 其他非流动金融资产 | 22,268,904.2 | 22,268,904.2 | 20,163,000 | 20,163,000 |
| 固定资产 | 275,214,094.74 | 263,947,407.47 | 270,885,418.32 | 277,866,690.74 |
| 在建工程 | 60,850,000 | 79,727,055.32 | 92,887,421.81 | 92,502,280.31 |
| 使用权资产 | 2,678,561.64 | 1,662,448.55 | 2,353,317.73 | 3,025,106.99 |
| 无形资产 | 25,699,361.73 | 27,853,249.98 | 33,956,005.99 | 36,217,367.89 |
| 商誉 | 3,509,512.35 | 3,509,512.35 | 11,120,561.81 | 11,120,561.81 |
| 长期待摊费用 | 1,319,878.85 | 1,464,950.24 | 1,622,954.37 | 1,799,531.15 |
| 递延所得税资产 | 14,173,355.34 | 13,748,168.57 | 26,459,090.45 | 23,446,286.82 |
| 其他非流动资产 | 276,603.78 | 276,603.78 | 324,086.94 | 309,778.84 |
| 非流动资产合计 | 449,131,417.75 | 457,599,445.58 | 507,694,217.7 | 514,372,964.83 |
| 资产总计 | 870,014,973.91 | 885,394,092.86 | 947,826,923.07 | 960,476,672.91 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 11,277,660.67 | 12,676,012.7 | 9,498,643.26 | 11,133,029.91 |
| 应付账款 | 11,277,660.67 | 12,676,012.7 | 9,498,643.26 | 11,133,029.91 |
| 合同负债 | 1,044,658.16 | 954,665.46 | 1,105,808.8 | 1,298,263.48 |
| 应付职工薪酬 | 3,708,900.42 | 8,553,281.98 | 10,235,740.95 | 8,480,327.64 |
| 应交税费 | 465,396.14 | 2,977,252.44 | 2,035,409.78 | 2,535,465.98 |
| 其他应付款合计 | 3,884,438.75 | 3,440,066.06 | 3,545,331.9 | 3,288,713.76 |
| 一年内到期的非流动负债 | 1,781,664.28 | 1,271,999.6 | 2,168,640.67 | 2,194,716.06 |
| 其他流动负债 | 290,854.52 | 939,955.57 | 358,030.05 | 767,131.48 |
| 流动负债合计 | 22,453,572.94 | 30,813,233.81 | 28,947,605.41 | 29,697,648.31 |
| 非流动负债: | | | | |
| 租赁负债 | 660,205.73 | - | 367,920 | 445,427.32 |
| 递延收益 | 2,332,057.95 | 1,865,586.55 | 2,067,343.89 | 2,151,718.92 |
| 递延所得税负债 | 1,933,797.09 | 3,409,777.97 | 3,523,534.07 | 3,922,661.78 |
| 其他非流动负债 | 3,300,000 | 3,085,000 | 4,585,000 | 4,735,000 |
| 非流动负债合计 | 8,226,060.77 | 8,360,364.52 | 10,543,797.96 | 11,254,808.02 |
| 负债合计 | 30,679,633.71 | 39,173,598.33 | 39,491,403.37 | 40,952,456.33 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 55,855,896 | 55,855,896 | 55,855,896 | 55,855,896 |
| 资本公积 | 732,161,074.7 | 732,161,074.7 | 732,161,074.7 | 732,161,074.7 |
| 减:库存股 | 17,025,758.17 | 17,025,758.17 | 17,025,758.17 | 17,025,758.17 |
| 其他综合收益 | -4,622,209.64 | -4,622,209.64 | - | - |
| 盈余公积 | - | - | 1,479,843.84 | 1,479,843.84 |
| 未分配利润 | 73,522,943.87 | 78,506,136.77 | 131,164,375.23 | 140,339,334.45 |
| 归属于母公司股东权益合计 | 839,891,946.76 | 844,875,139.66 | 903,635,431.6 | 912,810,390.82 |
| 少数股东权益 | -556,606.56 | 1,345,354.87 | 4,700,088.1 | 6,713,825.76 |
| 股东权益合计 | 839,335,340.2 | 846,220,494.53 | 908,335,519.7 | 919,524,216.58 |
| 负债和股东权益合计 | 870,014,973.91 | 885,394,092.86 | 947,826,923.07 | 960,476,672.91 |
| 公告日期 | 2026-04-28 | 2026-04-11 | 2025-10-29 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |